Steven A. Kaplan
YOU?
Author Swipe
View article: Correction: Extended LUTS medication use following BPH surgical treatment: a US healthcare claims analysis
Correction: Extended LUTS medication use following BPH surgical treatment: a US healthcare claims analysis Open
View article: Interim Valuations, Predictability, and Outcomes in Private Equity
Interim Valuations, Predictability, and Outcomes in Private Equity Open
View article: Extended LUTS medication use following BPH surgical treatment: a US healthcare claims analysis
Extended LUTS medication use following BPH surgical treatment: a US healthcare claims analysis Open
Background Postoperative medication use is an important yet relatively unexplored element of the benign prostatic hyperplasia patient journey. We assessed and compared the percentage of patients who required medication postoperatively afte…
View article: Extended LUTS Medication Use Following BPH Surgical Treatment: a US Healthcare Claims Analysis
Extended LUTS Medication Use Following BPH Surgical Treatment: a US Healthcare Claims Analysis Open
BACKGROUND Postoperative medication use is an important yet relatively unexplored element of the benign prostatic hyperplasia patient journey. We assessed and compared the percentage of patients who required medication postoperatively afte…
View article: WATER versus WATER II 5‐year update: Comparing <scp>Aquablation</scp> therapy for benign prostatic hyperplasia in 30–80‐cm<sup>3</sup> and 80–150‐cm<sup>3</sup> prostates
WATER versus WATER II 5‐year update: Comparing <span>Aquablation</span> therapy for benign prostatic hyperplasia in 30–80‐cm<sup>3</sup> and 80–150‐cm<sup>3</sup> prostates Open
Objective This study aims to compare the long‐term outcomes of Aquablation for small‐to‐moderate (30–80 cm 3 ) prostates with the outcomes for large (80–150 cm 3 ) prostates at 5‐year follow up. Methods The Waterjet Ablation Therapy for En…
View article: Limitations of ChatGPT for Patient Education Regarding Frequently Searched Questions About Benign Prostatic Hyperplasia
Limitations of ChatGPT for Patient Education Regarding Frequently Searched Questions About Benign Prostatic Hyperplasia Open
Purpose: Generative Pre-Trained Transformer 4 (GPT-4) or ChatGPT, an artificial intelligence language generator, has been used in multiple applications in medicine. We seek to evaluate ChatGPT’s ability to generate appropriate responses co…
View article: Long-term outcomes after treatment with Optilume BPH
Long-term outcomes after treatment with Optilume BPH Open
Introduction: The purpose of this study was to gather initial safety and efficacy data with the Optilume BPH Catheter System for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). Methods:…
View article: Pharmacokinetic Parameters of a Novel Sildenafil Oral Liquid Suspension Administered to Healthy Adult Men Under Fasted Conditions
Pharmacokinetic Parameters of a Novel Sildenafil Oral Liquid Suspension Administered to Healthy Adult Men Under Fasted Conditions Open
Sildenafil citrate is a phosphodiesterase type 5 inhibitor that has been proven safe and effective as an oral therapeutic agent for the treatment of erectile dysfunction. A novel liquid formulation of sildenafil citrate (ASP-001) has been …
View article: Two-year long-term follow-up of treatment with the Optilume BPH catheter system in a randomized controlled trial for benign prostatic hyperplasia (The PINNACLE Study)
Two-year long-term follow-up of treatment with the Optilume BPH catheter system in a randomized controlled trial for benign prostatic hyperplasia (The PINNACLE Study) Open
Background Patient outcomes were assessed 2 years after treatment with the Optilume BPH Catheter System, a minimally invasive surgical therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BP…
View article: The Role of Remote Diagnostics to Better Assess Uroflow Variability: Insights From Combining at Home Uroflows and Frequency Volume Charts From 19,868 Voids Using a Novel, Hand Held, Cellular Embedded Device
The Role of Remote Diagnostics to Better Assess Uroflow Variability: Insights From Combining at Home Uroflows and Frequency Volume Charts From 19,868 Voids Using a Novel, Hand Held, Cellular Embedded Device Open
Data show variability in voiding parameters, but similar average Qmax collected in 24 hours as compared to several days/weeks. The combination of home uroflowmetry with frequency-volume chart information can provide objective data and a un…
View article: Optilume BPH: 2-Year Results from A Prospective Multicenter Randomized Clinical Trial for the Treatment of Benign Prostatic Hyperplasia (The PINNACLE Study)
Optilume BPH: 2-Year Results from A Prospective Multicenter Randomized Clinical Trial for the Treatment of Benign Prostatic Hyperplasia (The PINNACLE Study) Open
Background Patient outcomes were assessed 2 years after treatment with the Optilume BPH Catheter System, a minimally invasive surgical therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BP…
View article: From BPH to male LUTS: a 20-year journey of the EAU guidelines
From BPH to male LUTS: a 20-year journey of the EAU guidelines Open
View article: The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia Open
The Optilume BPH Catheter System is a novel drug/device combination minimally invasive surgical therapy for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. The PINNACLE study is a prospective, rando…
View article: Retreatment Rates and Postprocedural Complications are Higher than Expected after BPH Surgeries: A US Healthcare Claims and Utilization Study
Retreatment Rates and Postprocedural Complications are Higher than Expected after BPH Surgeries: A US Healthcare Claims and Utilization Study Open
Background Up to 50% of men over 50 and 80% over 80 are affected by BPH. Shared decision-making regarding BPH treatment options can benefit from an improved understanding of relative risks and benefits for various treatments. Methods Data …
View article: COMPARING BPH-RELATED PROCEDURES ASSOCIATED WITH MEDICAL THERAPY TO TRADITIONAL SURGERY AND MIST USING A LARGE-SCALE REAL-WORLD DATABASE
COMPARING BPH-RELATED PROCEDURES ASSOCIATED WITH MEDICAL THERAPY TO TRADITIONAL SURGERY AND MIST USING A LARGE-SCALE REAL-WORLD DATABASE Open
View article: 12-MONTH OUTCOMES FROM A RANDOMIZED, DOUBLE-BLIND, SHAM CONTROLLED STUDY EVALUATING A NOVEL DRUG COATED BALLOON FOR THE TREATMENT OF BPH
12-MONTH OUTCOMES FROM A RANDOMIZED, DOUBLE-BLIND, SHAM CONTROLLED STUDY EVALUATING A NOVEL DRUG COATED BALLOON FOR THE TREATMENT OF BPH Open
View article: The Market for CEOs: Evidence from Private Equity
The Market for CEOs: Evidence from Private Equity Open
Most research on the CEO labor market studies public company CEOs while largely ignoring CEOs in private equity (PE) funded companies.We fill this gap by studying the market for CEOs among U.S. companies purchased by PE firms in large leve…
View article: A Survey of Private Debt Funds
A Survey of Private Debt Funds Open
Despite its large and increasing size in the U.S. and Europe, there is relatively little research on the private debt (PD) market, particularly compared to the bank and syndicated loan markets.Accordingly, in this paper, we survey U.S. and…
View article: Surgical Treatment for BPH Refractory to Medication: Robotic Water Jet Ablation vs TURP functional outcomes from two FDA clinical trials
Surgical Treatment for BPH Refractory to Medication: Robotic Water Jet Ablation vs TURP functional outcomes from two FDA clinical trials Open
Purpose A common indication for benign prostate hyperplasia (BPH) therapies is failure to improve with medical therapy. However, pivotal Federal Drug Administration (FDA) registered randomized clinical trials (RCTs) for minimally invasive …
View article: Prostatic artery embolization compared to trans-urethral resection of the prostate and prostatic urethral lift: A real-world population-based study
Prostatic artery embolization compared to trans-urethral resection of the prostate and prostatic urethral lift: A real-world population-based study Open
Background There are growing interests for minimally invasive surgical techniques (MISTs) for the treatment of benign prostatic hyperplasia (BPH) associated lower urinary tract symptoms (LUTS). Prostatic artery embolization (PAE) uses sele…
View article: Aquablation therapy in large prostates (80–150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3‐year trial results
Aquablation therapy in large prostates (80–150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3‐year trial results Open
Objective The objective of this study is to determine if Aquablation therapy can maintain its effectiveness in treating men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) with large‐volume (80–150 cc) pr…
View article: Correction to: An evaluation of the federal adverse events reporting system data on adverse effects of 5‑alpha reductase inhibitors
Correction to: An evaluation of the federal adverse events reporting system data on adverse effects of 5‑alpha reductase inhibitors Open
View article: Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease
Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease Open
View article: Correction: One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia
Correction: One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia Open
View article: Meta-analysis with individual data of functional outcomes following Aquablation for lower urinary tract symptoms due to BPH in various prostate anatomies
Meta-analysis with individual data of functional outcomes following Aquablation for lower urinary tract symptoms due to BPH in various prostate anatomies Open
Objectives To evaluate functional outcomes following Aquablation in various prostate volume and anatomical subgroups. Design A meta-analysis with individual patient data undergoing Aquablation therapy from four prospective, global, clinica…
View article: The endocannabinoid system, cannabis, and cannabidiol: Implications in urology and men's health
The endocannabinoid system, cannabis, and cannabidiol: Implications in urology and men's health Open
Background: The endocannabinoid system is a neuromodulatory system responsible for partial regulation of cognitive and emotional processes in the human central nervous system such as behavior, mood disorders, and neurologic disorders such …
View article: One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia
One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia Open
View article: WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30–80-cm3 and 80–150-cm3 Prostates
WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30–80-cm3 and 80–150-cm3 Prostates Open
Outcomes of Aquablation for both small-to-moderately-sized and large prostates are similar and sustainable at 2 yr of follow-up.
View article: Rezum therapy for patients with large prostates (≥ 80 g): initial clinical experience and postoperative outcomes
Rezum therapy for patients with large prostates (≥ 80 g): initial clinical experience and postoperative outcomes Open
View article: Male Voiding Behavior: Insight from 19,824 At-Home Uroflow Profiles
Male Voiding Behavior: Insight from 19,824 At-Home Uroflow Profiles Open
Assessment of 19,824 uroflows using an accurate and precise home uroflow device demonstrates that an individual's voiding parameters vary greatly from day to day, throughout the day, and worsen with age. Multiple measurements performed at …